FDA approves new agent for the treatment of metastatic prostate cancer. . BJU Int 2022;130:3-4.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. FDA approves new agent for the treatment of metastatic prostate cancer. BJU Int 2022;130:3-4.
PMID: 35768143